Trinity biotech receives regulatory approval to begin fda-cleared preclara™ preeclampsia testing service

New york state department of health (nysdoh) clinical laboratory permit facilitates q3 2025 launch of the fda-cleared preclara™ ratio (sflt-1/plgf) biomarker test for hypertensive disorders of pregnancy new york state department of health (nysdoh) clinical laboratory permit facilitates q3 2025 launch of the fda-cleared preclara™ ratio (sflt-1/plgf) biomarker test for hypertensive disorders of pregnancy
TRIB Ratings Summary
TRIB Quant Ranking